PROCEPT BioRobotics Corporation Stock
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.4 USD | +3.39% | -0.75% | +58.43% |
Financials (USD)
Sales 2024 * | 214M | Sales 2025 * | 300M | Capitalization | 3.41B |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -76M | EV / Sales 2024 * | 16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.4 x |
P/E ratio 2024 * |
-34.4
x | P/E ratio 2025 * |
-45.7
x | Employees | 626 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.75% |
Latest transcript on PROCEPT BioRobotics Corporation
1 day | +3.39% | ||
1 week | -0.75% | ||
1 month | +9.55% | ||
3 months | +35.34% | ||
6 months | +77.73% | ||
Current year | +58.43% |
Managers | Title | Age | Since |
---|---|---|---|
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Kevin Waters
DFI | Director of Finance/CFO | 46 | - |
Barry Templin
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frederic Moll
CHM | Chairman | 72 | 11-07-31 |
Taylor Harris
BRD | Director/Board Member | 48 | 20-11-30 |
Reza Zadno
CEO | Chief Executive Officer | 69 | 20-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.60% | 14 M€ | -5.07% | ||
0.05% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 66.4 | +3.39% | 730,045 |
24-05-30 | 64.22 | +0.19% | 406,461 |
24-05-29 | 64.1 | -0.59% | 687,876 |
24-05-28 | 64.48 | -3.62% | 630,047 |
24-05-24 | 66.9 | +0.25% | 693,999 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.43% | 3.41B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- PRCT Stock